These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2566388)

  • 21. Spontaneous incorporation of the glycosyl-phosphatidylinositol-linked protein Thy-1 into cell membranes.
    Zhang F; Schmidt WG; Hou Y; Williams AF; Jacobson K
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5231-5. PubMed ID: 1351678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Thy-1 antigen exhibits rapid lateral diffusion in the plasma membrane of rodent lymphoid cells and fibroblasts.
    Ishihara A; Hou Y; Jacobson K
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1290-3. PubMed ID: 2881297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biosynthesis of mouse Thy-1 antigen.
    Luescher B; Bron C
    J Immunol; 1985 Feb; 134(2):1084-9. PubMed ID: 2856927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new autoreactive monoclonal antibody specific for the Thy-1 antigen.
    Rabinowitz R; Hadar R; Laskov R; Schlesinger M
    Thymus; 1986; 8(5):279-94. PubMed ID: 2879369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cell hybrids that express a VH idiotope-related determinant on a glycoprotein distinct from H-2, Thy-1, and Lyt-1 molecules.
    Chanh TC; Cooper MD
    J Exp Med; 1983 Aug; 158(2):452-64. PubMed ID: 6193222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Busulfan and chloramphenicol induced T cell lymphoma: cell surface characteristics and functional properties.
    Bhoopalam N; Price K; Norgello H; Barone-Varelas J; Fried W
    Clin Exp Immunol; 1986 Jun; 64(3):646-55. PubMed ID: 2947760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic and functional properties of murine thymocytes. I. Precursors of cytolytic T lymphocytes and interleukin 2-producing cells are all contained within a subpopulation of "mature" thymocytes as analyzed by monoclonal antibodies and flow microfluorometry.
    Ceredig R; Glasebrook AL; MacDonald HR
    J Exp Med; 1982 Feb; 155(2):358-79. PubMed ID: 6120202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence from neuron/lymphoma heterokaryons for a common trans-acting factor suppressing Thy-1 expression.
    Saleh M; Barlett PF
    J Neuroimmunol; 1989 Aug; 23(3):203-14. PubMed ID: 2568997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of solubilized tumor antigen extracted from P1798 murine lymphoma cells or isolated from tumor-bearer ascites fluid and reactivity with anti-thy-1.2 antiserum.
    Gordon WC; Baechtel FS; Goetz G; Prager MD
    Int J Cancer; 1977 May; 19(5):692-9. PubMed ID: 68017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the Thy-1 pathway of T cell hybridoma activation using 17 rat monoclonal antibodies reactive with distinct Thy-1 epitopes.
    Pont S; Regnier-Vigouroux A; Naquet P; Blanc D; Pierres A; Marchetto S; Pierres M
    Eur J Immunol; 1985 Dec; 15(12):1222-8. PubMed ID: 2417861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Thy-1 on human hematopoietic progenitor cells.
    Craig W; Kay R; Cutler RL; Lansdorp PM
    J Exp Med; 1993 May; 177(5):1331-42. PubMed ID: 7683034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A human thy-1-like antigen expressed on cultured leukemic T-cells.
    Saji F; Tanigaki N
    Immunogenetics; 1982; 15(6):551-63. PubMed ID: 6125472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of a lymphocyte differentiating factor (ELDIF) by cultured human epidermal cells.
    Nicolas JF; Dardenne M; Faure M; Gaucherand M; Gagneraut MC; Thivolet J; Bach JF
    Immunol Lett; 1985; 9(2-3):65-8. PubMed ID: 2859244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic correction of defects in the lipid anchoring of Thy-1 in lymphoma mutants.
    Gupta D; Tartakoff A; Tisdale E
    Science; 1988 Dec; 242(4884):1446-8. PubMed ID: 2904699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular comparison of mouse Thy-1 and its human homologue.
    Bonewald L; Wang AC; Terry E; Zwerner R; Balch CM; Ades EW
    Mol Immunol; 1982 Mar; 19(3):497-501. PubMed ID: 6124880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
    Kummer U; Haunschild J; Reisbach G; Delecluse HJ; Thierfelder S
    Eur J Immunol; 1993 Oct; 23(10):2649-54. PubMed ID: 8104797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 51cr-release assay for quantitation of membrane bound and solubilized Thy-1 antigen.
    Carlsson S; Stigbrand T; Winblad B
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):9-13. PubMed ID: 6974950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Thy-1 antigen: cell surface expression on early T and B lymphocytes.
    Ritter MA; Sauvage CA; Delia D
    Immunology; 1983 Jul; 49(3):555-64. PubMed ID: 6134665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of a T cell receptor-like molecule on normal and malignant murine T cells detected by rat monoclonal antibodies to nonclonotypic determinants.
    Chan PY; Takei F
    J Immunol; 1986 Feb; 136(4):1346-53. PubMed ID: 2418112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.